| Nr. | Year OPEN | Title | users say | rate good | rate bad | no link | Citation |
|---|
Emesis chemotherapy associatedCasopitantNabilone| 1 | 2004 | The pathophysiology of treatment-related nausea and vomiting in cancer patients: current models. | 
| + | - | nl | Indian J Physiol Pharmacol 48(3):256-68 (2004) |
| 2 | 2009 | Casopitant: a novel NK(1)-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting. |
| + | - | nl | Ther Clin Risk Manag 5(2):375-84 (2009) |
| 3 | 2008 | A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting. |
| + | - | nl | Ther Clin Risk Manag 4(1):99-107 (2008) |
| 4 | 2008 | Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis. |
| + | - | nl | Ann Oncol 19 Suppl 2(-):ii110-2 (2008) |
| 5 | 2008 | Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting. |
| + | - | nl | Cancer 112(9):2080-7 (2008) |
| 6 | 2007 | Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations. |
| + | - | nl | Oncologist 12(9):1143-50 (2007) |
| 7 | 2003 | Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control. |
| + | - | nl | Oncologist 8(2):187-98 (2003) |
| 8 | 2004 | The management of vomiting due to chemotherapy. |
| + | - | nl | Acta Med Indones 36(4):219-26 (2004) |
| 9 | 2005 | ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV). |
| + | - | nl | Ann Oncol 16 Suppl 1(-):i77-9 (2005) |
| 10 | 2007 | Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis. |
| + | - | nl | Ann Oncol 18 Suppl 2(-):ii83-5 (2007) |
| 11 | 2009 | Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis. |
| + | - | nl | Ann Oncol 20 Suppl 4(-):156-8 (2009) |
| 12 | 2006 | Benefits and adverse effects of anti-emetic glucocorticoids in cancer. |
| + | - | nl | Cancer Biol Ther 5(8):921-2 (2006) Bruning A |
| 13 | 2008 | Why is the neurobiology of nausea and vomiting so important? |
| + | - | nl | Appetite 50(2-3):430-4 (2008) |
| 14 | 2006 | Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases. |
| + | - | nl | Auton Neurosci 125(1-2):100-15 (2006) |
| 15 | 2007 | Chemotherapy induced nausea and vomiting--prevention and treatment. |
| + | - | nl | Aust Fam Physician 36(9):702-6 (2007) |
| 16 | 2009 | Nausea and vomiting in people with cancer and other chronic diseases. |
| + | - | nl | Clin Evid (Online) 2009(-):- (2009) |
| 17 | 2007 | Management of intractable nausea and vomiting in patients at the end of life: "I was feeling nauseous all of the time . . . nothing was working". |
| + | - | nl | JAMA 298(10):1196-207 (2007) |
| 18 | 2010 | Management of chemotherapy-induced nausea and vomiting. | 
| + | - | nl | Indian Pediatr 47(2):149-55 (2010) |
